Dongyan Shen
Xiamen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Case Report: CD19 CAR-T therapy induces durable remission in a pediatric patient with TP53-mutated, refractory Burkitt lymphoma: a 30-month follow-up.
Journal: Frontiers in oncology
Published: September 10, 2025
Retinoic acid receptor gamma (RARγ) drives M2-like macrophage polarisation via CFI to promote thyroid cancer progression.
Journal: International immunopharmacology
Published: August 26, 2025
A metal-phenolic nanotuner induces cancer pyroptosis for sono-immunotherapy.
Journal: Biomaterials science
Published: December 10, 2024
IL6/STAT3 induced GRWD1 mediates aerobic glycolysis via P53/GLUT1 signal axis in colon carcinoma.
Journal: Scientific reports
Published: November 29, 2024
RBM39 Functions as a Potential Oncogene Through the NF-κB Signaling Pathway in Colorectal Cancer Cells.
Journal: Journal of Cancer
Published: October 13, 2024
Correction to: miR‑9‑5p Suppresses Malignant Biological Behaviors of Human Gastric Cancer Cells by Negative Regulation of TNFAIP8L3.
Journal: Digestive diseases and sciences
Published: September 11, 2024
Modulation of lipid profile by secretory phospholipase A2 group IIA: Verification with a transgenic mouse model.
Journal: Biochemical and biophysical research communications
Published: April 02, 2024
KHDRBS1 as a novel prognostic signaling biomarker influencing hepatocellular carcinoma cell proliferation, migration, immune microenvironment, and drug sensitivity.
Journal: Frontiers in immunology
Published: February 29, 2024
Exploring SLC16A1 as an Oncogenic Regulator and Therapeutic Target in Cholangiocarcinoma.
Journal: Journal of Cancer
Published: February 11, 2024
Downregulation of dermatopontin in cholangiocarcinoma cells suppresses CCL19 secretion of macrophages and immune infiltration.
Journal: Journal of cancer research and clinical oncology
Published: September 29, 2023
DPY30 promotes colorectal carcinoma metastasis by upregulating ZEB1 transcriptional expression.
Journal: Cancer cell international
Published: August 28, 2023
Last Updated: 09/26/2026